Analyst firms · Oppenheimer · AUPH

Oppenheimer AUPH price target and rating history

Aurinia Pharmaceuticals Inc (AUPH) · Health Care

Oppenheimer rates Aurinia Pharmaceuticals Inc (AUPH) Perform with a $31 price target, as of its latest action on Nov 4, 2022. It has published 4 rating actions on AUPH since October 2021, including 1 upgrade and 2 downgrades.

Current rating
Perform
Price target
$31
Median target, all firms
Too few
Actions on AUPH
4

Oppenheimer price target on AUPH

$33$32$3120222023202420252026
Oppenheimer price target on AUPH, each point a stated target, October 2021 to December 2021.

Every Oppenheimer rating on AUPH

Questions about Oppenheimer and AUPH

What is Oppenheimer's price target for AUPH?
Oppenheimer's latest stated price target for Aurinia Pharmaceuticals Inc (AUPH) is $31, from its action on Dec 10, 2021.
What is Oppenheimer's rating on AUPH?
Oppenheimer rates AUPH Perform, a neutral rating, as of Nov 4, 2022.
When did Oppenheimer last change its view on AUPH?
On Nov 4, 2022, Oppenheimer downgrades to Perform from Outperform.

More AUPH rating histories

All Oppenheimer ratingsAUPH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.